Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives. (November 2010)
- Record Type:
- Journal Article
- Title:
- Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives. (November 2010)
- Main Title:
- Inhibition of P-glycoprotein pumps by PEO–PPO amphiphiles: branched versus linear derivatives
- Authors:
- Alvarez-Lorenzo, Carmen
Rey-Rico, Ana
Brea, Jose
Loza, Maria Isabel
Concheiro, Angel
Sosnik, Alejandro - Abstract:
- Inhibition of the activity of efflux transporters may relevantly improve the chemotherapy of cancer and infectious diseases.Aim: To explore the ability of poloxamines (Tetronic ®, X-shaped structure with a central ethylendiamine group and four branches of poly[ethylene oxide]–poly[propylene oxide] [PEO–PPO]) to inhibit the activity of P-glycoprotein (P-gp) on Caco-2 cell monolayers and to elucidate the incidence of the molecular architecture of PEO–PPO block copolymers on the intracellular accumulation of a relevant substrate, doxorubicin, by comparison with poloxamers (Pluronic ®, linear triblock copolymers), well-known inhibitors of this efflux transporter.Methods: Both pristine and N -methylated poloxamines displaying a wide range of molecular weights and EO/PO ratios were tested regarding cytocompatibility and accumulation of doxorubicin in Caco-2 monolayers. Verapamil was used as a control.Results: The most active anti-P-gp poloxamines (which enhanced two- to three-fold doxorubicin accumulation compared with verapamil) resulted to be pristine medium-to-high hydrophobic T304, T904, T1301, T901 and T150R1. A notable dependence of the anti-P-gp activity on the copolymer concentration was found. A joint diagram of the inhibitory activity of poloxamers and poloxamines as a function of the effective length of the PPO block is proposed.Conclusion: The anti-P-gp activity is maxima for block copolymers possessing a low-to-medium hydrophilic–lipophilic balance and an 'effectiveInhibition of the activity of efflux transporters may relevantly improve the chemotherapy of cancer and infectious diseases.Aim: To explore the ability of poloxamines (Tetronic ®, X-shaped structure with a central ethylendiamine group and four branches of poly[ethylene oxide]–poly[propylene oxide] [PEO–PPO]) to inhibit the activity of P-glycoprotein (P-gp) on Caco-2 cell monolayers and to elucidate the incidence of the molecular architecture of PEO–PPO block copolymers on the intracellular accumulation of a relevant substrate, doxorubicin, by comparison with poloxamers (Pluronic ®, linear triblock copolymers), well-known inhibitors of this efflux transporter.Methods: Both pristine and N -methylated poloxamines displaying a wide range of molecular weights and EO/PO ratios were tested regarding cytocompatibility and accumulation of doxorubicin in Caco-2 monolayers. Verapamil was used as a control.Results: The most active anti-P-gp poloxamines (which enhanced two- to three-fold doxorubicin accumulation compared with verapamil) resulted to be pristine medium-to-high hydrophobic T304, T904, T1301, T901 and T150R1. A notable dependence of the anti-P-gp activity on the copolymer concentration was found. A joint diagram of the inhibitory activity of poloxamers and poloxamines as a function of the effective length of the PPO block is proposed.Conclusion: The anti-P-gp activity is maxima for block copolymers possessing a low-to-medium hydrophilic–lipophilic balance and an 'effective number' of PO units ranging from 30 to 50. … (more)
- Is Part Of:
- Nanomedicine. Volume 5:Number 9(2010)
- Journal:
- Nanomedicine
- Issue:
- Volume 5:Number 9(2010)
- Issue Display:
- Volume 5, Issue 9 (2010)
- Year:
- 2010
- Volume:
- 5
- Issue:
- 9
- Issue Sort Value:
- 2010-0005-0009-0000
- Page Start:
- 1371
- Page End:
- 1383
- Publication Date:
- 2010-11
- Subjects:
- cancer -- doxorubicin -- drug efflux -- HIV/AIDS -- P-glycoprotein inhibition -- poloxamer -- poloxamine -- polymeric micelle -- transport
Nanotechnology -- Periodicals
Medical technology -- Periodicals
Nanotechnology -- Therapeutic use -- Periodicals
610.28 - Journal URLs:
- http://www.futuremedicine.com/loi/nnm ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/nnm.10.53 ↗
- Languages:
- English
- ISSNs:
- 1743-5889
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.015000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 15313.xml